Ted Karkus - 17 Mar 2024 Form 4/A Insider Report for ProPhase Labs, Inc. (PRPH)

Role
CEO & CHAIRMAN, Director, 10%+ Owner
Signature
/s/ Ted Karkus
Issuer symbol
PRPH
Transactions as of
17 Mar 2024
Transactions value $
$0
Form type
4/A
Filing time
21 Mar 2024, 16:30:10 UTC
Date Of Original Report
19 Mar 2024
Previous filing
05 Apr 2023
Next filing
11 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Award $0 +400,000 $0 400,000 17 Mar 2024 Common Stock 400,000 $6 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.
F2 This amended report on Form 4 is being filed to correct the information in Table II, Box 5 as the share amount was inadvertently reported under the wrong subheading in the original Form 4 filed on March 19, 2024.